Position in DHR
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,001,373
+$10,005 QoQ
Shares Held
10,507
+0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#891
of 2,098 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PETREDIS INVESTMENT ADVISORS LLC holds $5,518,413 across 2 Diagnostics & Research names. DHR ranks #2 (36.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
7,015 | $3,517,040 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
10,507 | $2,001,373 |
All Filings in DHR
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,001,373 | 10,507 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,991,368 | 10,503 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $2,428,154 | 10,607 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,129,114 | 10,739 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $2,153,383 | 10,901 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $2,201,495 | 10,739 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $2,406,602 | 10,484 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $2,984,822 | 10,736 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $2,673,894 | 10,702 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $2,674,501 | 10,710 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,409,637 | 10,416 | Shares | Sole | 2024-05-20 | |
| 2023-09-30 | $2,663,601 | 10,736 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $2,570,880 | 10,712 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $2,700,860 | 10,716 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $2,809,470 | 10,585 | Shares | Sole | 2024-05-20 | |
| No filing history on record for this holder in this stock. | ||||||